|
|
|||
|
||||
OverviewPharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D. Full Product DetailsAuthor: Oliver Gassmann , Gerrit Reepmeyer , Maximilian von ZedtwitzPublisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Imprint: Springer-Verlag Berlin and Heidelberg GmbH & Co. K Edition: Softcover reprint of hardcover 2nd ed. 2008 Dimensions: Width: 15.50cm , Height: 1.00cm , Length: 23.50cm Weight: 0.320kg ISBN: 9783642096389ISBN 10: 3642096387 Pages: 186 Publication Date: 06 November 2010 Audience: Professional and scholarly , Professional & Vocational Replaced By: 9783319668321 Format: Paperback Publisher's Status: Out of Print Availability: In Print Limited stock is available. It will be ordered for you and shipped pending supplier's limited stock. Table of ContentsInnovation: Key to Success in the Pharmaceutical Industry.- The Industry Challenge: Do You Really Want to Be in This Business?.- The Science and Technology Challenge: How to Find New Drugs.- The Pipeline Management Challenge: How to Organize Innovation.- The Internationalization Challenge: Where to Get Access to Innovation.- Management Answers to Pharmaceutical R&D Challenges.- Future Directions and Trends.ReviewsFrom the reviews: This book examines the international pharmaceutical industry with special emphasis on the current and emerging research methodologies ! . What distinguishes this book from others on the same subject is its emphasis on empirical findings (53 figures, 20 tables) and an exceptionally good, if short, discussion of various research technologies ! . The six-page glossary of industry terms, when used with its decent index, is a particular joy. ! recommend this offering to prospective managers and researchers in this industry ! . (Robert R. Rothberg, Journal of Product Innovation Management, Vol. 22, 2005) From the reviews of the second edition: Leading Pharmaceutical Innovation, Gassmann and colleagues describe the current status of the pharmaceutical industry ! . This book comprises seven chapters, where each could be seen as a review of the addressed topic. This helps with understanding the complexity of the challenges the pharmaceutical industry is facing, in comparison to the automotive industry or with respect to marketing problems ! . book provides most valuable insight into the pharmaceutical industry from an 'outsiders' perspective. (Sandrine Shepard and Thomas Wilckens, R&D Management, Vol. 40 (5), November, 2010) From the reviews: This book examines the international pharmaceutical industry with special emphasis on the current and emerging research methodologies ! . What distinguishes this book from others on the same subject is its emphasis on empirical findings (53 figures, 20 tables) and an exceptionally good, if short, discussion of various research technologies ! . The six-page glossary of industry terms, when used with its decent index, is a particular joy. ! recommend this offering to prospective managers and researchers in this industry ! . (Robert R. Rothberg, Journal of Product Innovation Management, Vol. 22, 2005) Author InformationTab Content 6Author Website:Countries AvailableAll regions |